This patent covers the OsteoBoost tracking and reporting features, as well as for a wearable apparatus for treating or preventing osteoporosis.
Bone Health Technologies, a leading innovator of progressive new therapies for improving bone health, today announced that the United States Patent and Trademark Office (USPTO) has awarded its second patent for the OsteoBoost Vibration Belt. The Company has patents filed in multiple countries – the United States, Europe, Japan, and South Korea.
This patent covers the OsteoBoost tracking and reporting features, as well as for a wearable apparatus for treating or preventing osteoporosis. This patent builds on a previously awarded patent for devices and methods to dynamically calibrate the precise therapeutic vibration of the OsteoBoost Vibration Belt.
“Osteopenia and Osteoporosis are a major public health problem in need of innovation – I am proud of the work we are doing to bring safe and effective treatments to the tens of millions of patients at risk of fracture and are thrilled to see the novelty of this mechanism recognized.” said Laura Yecies, CEO of Bone Health Technologies.
The company recently announced the close of its $2.5 million funding round and the appointment of three board members. The round and board appointments add to a successful year for BHT. It recently appointed CEO Laura Yecies and was granted Breakthrough Device Designation by the FDA for OsteoBoost, the first vibration belt specifically designed for the treatment of osteopenia and prevention of osteoporosis. At the 2021 One Harvard New Venture Competition, Bone Health Technologies was awarded both the One Harvard New Venture Competition Grand Prize Winner and Northern California Crowd Favorite titles and won the grand prize at the 2021 Dartmouth Entrepreneur Competition.
OsteoBoost is based on NASA research which proved that medical stimulation of bones through vibration would improve bone health in astronauts. Studies have shown that one 30-minute treatment with OsteoBoost reduced bone loss activity in all study participants.
For more information on the CEO appointment or Bone Health Technologies and OsteoBoost please visit: http://www.bonehealthtech.com/